tradingkey.logo
tradingkey.logo
Suchen

Amneal Pharmaceuticals Inc

AMRX
Zur Watchlist hinzufügen
17.310USD
+0.020+0.12%
Handelsschluss 06/30, 16:00ETKurse um 15 Minuten verzögert
5.52BMarktkapitalisierung
44.64KGV TTM

mehr Informationen über Amneal Pharmaceuticals Inc Unternehmen

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Amneal Pharmaceuticals Inc Informationen

BörsenkürzelAMRX
Name des UnternehmensAmneal Pharmaceuticals Inc
IPO-datumNov 18, 2009
CEOPatel (Chintu)
Anzahl der mitarbeiter8100
WertpapierartOrdinary Share
GeschäftsjahresendeNov 18
Addresse400 Crossing Boulevard, 3rd Floor
StadtBRIDGEWATER
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl08807
Telefon19089473120
Websitehttps://amneal.com/
BörsenkürzelAMRX
IPO-datumNov 18, 2009
CEOPatel (Chintu)

Führungskräfte von Amneal Pharmaceuticals Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Amneal Pharmaceuticals Inc?

Die fünf größten Anteilseigner von Amneal Pharmaceuticals Inc sind: Mr. Chintu Patel

Wie viele Institutionen halten Anteile an Amneal Pharmaceuticals Inc (AMRX)?

Mit Stand vom 2026Q1 halten 521 Institutionen Anteile an Amneal Pharmaceuticals Inc, mit einem Gesamtmarktwert von etwa 161.64M, was 50.67% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -25718515.00 gestiegen.

Was ist die größte Einnahmequelle von Amneal Pharmaceuticals Inc?

Am 2026Q1 erzielte das Geschäft mit Oral solid für Amneal Pharmaceuticals Inc den höchsten Umsatz in Höhe von 726.38M, was 24.06% des Gesamtumsatzes entspricht.
KeyAI